CPhI China opens as country invests in R&D
22 June 2015 | By
CPhI China, hosted by UBM EMEA and CCCMHPIE, returns to the Shanghai New International Exhibition Centre, SNIEC, China from 24 to 26 June 2015...
List view / Grid view
News
Celsis introduces the all new Celsis Accel™ Rapid Microbial Screening System for midrange test volumes
20 June 2015 | By Celsis International
Celsis’ Accel System for Pharma allows products to be quickly released from micro hold, diminishing manufacturing cycle times and reducing inventory and working capital requirements...
CYRAMZA® (ramucirumab) Hepatocellular Carcinoma data published by The Lancet Oncology
19 June 2015 | By Eli Lilly and Company
Encouraging subgroup findings are basis for new phase III trial...
AOP Orphan strengthens core CNS specialty business with high promise in movement disorder treatments
19 June 2015 | By AOP Orphan Pharmaceuticals AG
AOP Orphan Pharmaceuticals AG has announced the regulatory submission of Tetrabenazine for the treatment of tardive dyskinesia in a DCP (decentralized procedure) for several European countries with UK being reference member state...
Bristol-Myers Squibb to present data from the Orencia Phase IIIb AVERT and AMPLE trials
19 June 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb has announced results from new post hoc analyses of the Phase 3b AVERT and AMPLE trials, which included early moderate to severe rheumatoid arthritis (RA) patients with active disease and markers of poor prognosis...
Galapagos completes recruitment for ORIGIN Phase 2 trial with GLPG1205 in ulcerative colitis patients
18 June 2015 | By Victoria White
Galapagos has completed recruitment for the Phase 2 Proof-of-Concept study in ulcerative colitis with GPR84 inhibitor GLPG1205...
Azithromycin proves strikingly effective against drug-resistant superbugs
18 June 2015 | By Victoria White
A new study shows that the antibiotic azithromycin, often prescribed to cure common infections, kills many multidrug-resistant bacteria very effectively...
LY2951742 met the primary endpoint in a Phase 2b study in episodic migraine
18 June 2015 | By Victoria White
Lilly’s investigational medicine for the prevention of migraine, LY2951742, met the primary endpoint in a Phase 2b study in episodic migraine...
NICE seeks more information on idelalisib from Gilead
18 June 2015 | By Victoria White
NICE has opened a consultation on preliminary draft guidance for the drug idelalisib (Zydelig) for adults with chronic lymphocytic leukaemia...
Roche to provide HIV diagnostic solutions to Global Fund
18 June 2015 | By Victoria White
Roche has been selected to provide HIV-1 viral load and early infant diagnostic technologies for the Global Fund...
New mandatory logo for selling medicines online
18 June 2015 | By Victoria White
From 1 July, anyone in the UK selling medicines online needs to be registered with the MHRA and to be on the MHRA’s list of registered online retail sellers...
BGMA and MHRA come together for Quality Forum
The British Generic Manufacturers Association (BGMA) will stage the next meeting of its Quality Forum – in conjunction with the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) - on Wednesday, July 8th.
Boston Scientific launches Precision Novi Spinal Cord Stimulator System in Europe
18 June 2015 | By Victoria White
Boston Scientific has launched the Precision Novi Spinal Cord Stimulator System in Europe. It is the smallest high-capacity primary cell device available...
Merck Serono commits € 1.2 million to the Grant for Fertility Innovation (GFI) for 2015 / 16
18 June 2015 | By Victoria White
Merck Serono has announced its strong support of the Grant for Fertility Innovation (GFI) fund with grants totalling up to € 1.2 million for 2015 / 2016...
Genticel receives FDA clearance of IND application for US Phase 1 clinical trial of GTL001
17 June 2015 | By Victoria White
The FDA has cleared Genticel’s IND application to conduct in the US a Phase 1 study of GTL001 in patients infected with HPV 16 and/or 18...
